Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for April 24, 2015

April 24, 2015 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Burr introduces fast-track FDA bill

April 24, 2015 by Brad Perriello

Sen. Richard Burr (R-N.C.) introduces a new bill to create fast-track approvals at the FDA for breakthrough medical devices.

Burr introduces fast-track FDA bill

A new Senate bill introduced yesterday would create a fast-track program at the FDA for breakthrough medical devices

The bill, S. 1077 or " A bill to provide for expedited development of and priority review for breakthrough devices," was sponsored by Sen. Richard Burr (R-N.C.) and co-sponsored by Sens. Orrin Hatch (R-Utah) and Michael Bennet (D-Colo.).

Gynesonics raises $3m for VizAblate fibroid device

April 24, 2015 by Mark Hollmer

Gynesonics pulls in $3 million in a new debt financing that will help fuel further development of its VizAblate fibroid treatment device.

Gynesonics raises $3m for VizAblate fibroid device

California's Gynesonics reported raising $3 million in a new debt offering as it pursues development of its VizAblate fibroid treatment device.

Spectranetics to boost Stellarex spend

April 24, 2015 by Brad Perriello

Spectranetics says it plans to boost its R&D spend on the Stellarex drug-eluting balloon it bought from Covidien.

Spectranetics to boost Stellarex spend

Halloran Consulting Group Helps Life Science Companies Develop, Manage, and Adhere to Clinical Study Budgets

April 24, 2015 by MassDevice

Halloran expands clinical finance services and licenses leading industry financial forecasting tool to effectively budget and manage clinical trial budgets.

BOSTON, MA – Halloran Consulting Group, the life science management consulting firm, expands its robust range of clinical finance capabilities with the addition of the industry's leading financial forecasting tool.

Bard shares tick up on Q1 earnings beat

April 24, 2015 by Brad Perriello

Share prices tick up for C.R. Bard after it reports a 1st-quarter earnings beat.

Bard shares tick up on Q1 earnings beat

C.R. Bard (NYSE:BCR) shares gained today after the medical products giant reported 1st-quarter earnings that topped expectations on Wall Street, despite a poor quarterly comparison for its Lutonix drug-eluting balloon.

TAVI: Edwards CEO says Sapien 3 could hit U.S. market this year

April 24, 2015 by Brad Perriello

Edwards Lifesciences CEO Michael Mussallem says the company now expects the FDA to approve its next-generation Sapien 3 replacement heart valve this year.

TAVI: Edwards CEO says Sapien 3 could hit U.S. market this year